LOCATION: | AADATpeptidecorrespondsto12aminoacidsofAADAT. |
---|---|
SPECIES: | Human |
TESTEDAPPLICATIONS: | Blocking |
APPLICATIONS: | AADATpeptideisusedforblockingtheactivityofAADATantibody(catalognumber43-121).TheAADATantibodyshipsat0.5mg/mLandtheSTK36Peptideshipsasa100ugpellet.Whenpeptideisreconstitutedin200uLwater,theconcentrationwillbe0.5mg/mL,identicaltothatoftheantibody.Thebeststartingratiowouldbe1:1(whichmeansmolarexcessofpeptiderelativetoantibodywhenidenticalvolumesaremixed).Mixequalvolumeofpeptideandantibodyattherequireddilutionandleaveatambienttemperaturefor20minutes.Thenincubateanddevelopinparalleltwoblots:onewiththeantibodyandonewiththeantibodywhichhasbeenpre-absorbedwiththeprovidedpeptide.. |
PHYSICALSTATE: | Lyophilized |
---|---|
BUFFER: | AADATpeptideissuppliedas100μgofdriedpeptide.Whenthepeptideisreconstitutedin200μLwater,theconcentrationwillbe0.5mg/mL. |
STORAGECONDITIONS: | Storeat-20˚C.Whenreconstitutedminimizefreezingandthawing. |
ALTERNATENAMES: | AADAT,aminoADIpateaminotransferase,KAT2,KATII,Lkynurenine/alphaaminoadipateaminotransferase,L-kynurenine/alpha-aminoadipateaminotransferase,alpha-aminoadipateaminotransferase,kynurenineaminotransferaseII |
---|---|
ACCESSIONNO.: | NP_057312.1,NP_872603.1 |
PROTEINGINO.: | 7705897 |
ProSci Inc.始终开放以支持研究需求,同时确保我们员工的健康和安全。ProSci拥有广泛的冠状病毒SARS-CoV-2 重组蛋白和抗体产品组合, 并将继续积极开发新的冠状病毒 产品。此外,ProSci的定制抗体服务也保持开放状态,以支持研究团体开发 研究工具,诊断,疗法和疫苗。